Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo Biloba Dispersible Tablets for Mild to Moderate Alzheimer's Disease
NCT03090516Phase 3Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Aug 2016
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ginkgo biloba extract in Alzheimer's disease (AD) (3 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Minimum Mental State Examination at 12 weeks, Electroencephalography P300 at 12 weeks and 7 more. Status: unknown.
02
Drugs
ginkgo biloba extract
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03090516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03090516.